Reproducible nigral cell loss after systemic proteasomal inhibitor administration to rats
- 1 August 2006
- journal article
- editorial
- Published by Wiley in Annals of Neurology
- Vol. 60 (2), 248-252
- https://doi.org/10.1002/ana.20932
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neuronsAnnals of Neurology, 2006
- Proteasome inhibitor-induced model of Parkinson's diseaseAnnals of Neurology, 2006
- Protein aggregation in the pathogenesis of familial and sporadic Parkinson's diseaseNeurobiology of Aging, 2006
- Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's diseaseAnnals of Neurology, 2004
- Oxidative stress in Parkinson's diseaseAnnals of Neurology, 2003
- Proteasome inhibition causes nigral degeneration with inclusion bodies in ratsNeuroReport, 2002
- Impairment of the ubiquitin‐proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic culturesJournal of Neurochemistry, 2002
- Failure of the ubiquitin–proteasome system in Parkinson's diseaseNature Reviews Neuroscience, 2001
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences of the United States of America, 1998
- The reliability of the hole-board apparatusPsychopharmacology, 1975